Updated Jul 16, 2026
Shantharam Harish is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days. Lifetime open-market purchases: $58K.
Harish Shantharam is the Chief Financial Officer of ALX Oncology Holdings Inc, a clinical-stage immuno-oncology company. He has been involved in the financial management of the company as it develops innovative cancer therapies.
| Role | Insider |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2025-08-18 | ALXO | ALX ONCOLOGY HOLDINGS INC | P — Open-market purchase | 75.0K | $0.78 | $58K |
Harish Shantharam is the Chief Financial Officer of ALX Oncology Holdings Inc, a clinical-stage immuno-oncology company. He has been involved in the financial management of the company as it develops innovative cancer therapies.…
Recorded transactions: 1 open-market purchases ($58K) and 0 open-market sales () across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Shantharam Harish profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.